The DOI matches its Crossref record.
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
Abstract
Recombinant human lymphotoxin (LT) was compared with recombinant human tumor necrosis factor (TNF) for direct actions on cultured human endothelial cells (HEC). At equivalent half-maximal concentrations (based on L929 cytotoxicity units) LT and TNF each caused rapid and transient induction (peak 4 to 6 hr) of an antigen associated with leukocyte adhesion (detected by monoclonal antibody H4/18), a rapid but sustained increased expression (plateau 24 hr) of a lymphocyte adhesion structure (ICAM-1), a gradual (plateau 4 to 6 days) increase in expression of HLA-A,B antigens, and gradual (4 to 6 days) conversion of HEC culture morphology from epithelioid to fibroblastoid, an effect enhanced by immune interferon (IFN-gamma). Induction of H4/18 binding by maximal concentrations of LT or TNF could not be augmented by addition of the other cytokine, and 24 hr pretreatment with LT or TNF produced hyporesponsiveness to both mediators for reinduction. H4/18 binding can be transiently induced by tumor-promoting phorbol esters. Pretreatment with either LT or TNF also fully inhibited induction of H4/18 binding by phorbol ester, whereas phorbol ester pretreatment only variably and partially inhibited reinduction by LT or TNF. These actions of LT on endothelium shared with TNF may serve in vivo to promote lymphocyte and inflammatory leukocyte adhesion and transendothelial migration. Recombinant human interleukin 1 species (IL 1 alpha and IL 1 beta) shared many of the actions of LT and TNF and were indistinguishable from each other. However, IL 1 species could be distinguished from LT/TNF by their relative inability to enhance HLA-A,B expression, by their ability to augment H4/18 binding caused by maximally effective concentrations of LT or TNF, and by their inability to inhibit reinduction of H4/18 binding by LT or TNF. In contrast to the actions of LT or TNF, pretreatment with IL 1 alpha or IL 1 beta only partially inhibited induction of H4/18 binding by phorbol ester, and phorbol ester pretreatment consistently, albeit partially, inhibited induction by IL 1 species. These studies suggest that activated T cells through the secretion of LT can in turn activate the local endothelial lining so as to promote homing and extravasation of inflammatory cells. Furthermore, these LT actions can be augmented or complemented by other locally produced mediators such as IFN-gamma or IL 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022
Self-citationMarlin, S. D., & Springer, T. A. (1987) · Cell · doi:10.1016/0092-8674(87)90104-8 · Cited by 1,674
Self-citationBone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
The major human rhinovirus receptor is ICAM-1
Greve, J. M., Davis, G., Meyer, A. M., Forte, C. P., Yost, S. C., Marlor, C. W., Kamarck, M. E., & McClelland, A. (1989) · Cell · doi:10.1016/0092-8674(89)90688-0 · Cited by 1,148
Smith, C. W., Marlin, S. D., Rothlein, R., Toman, C., & Anderson, D. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114111 · Cited by 1,092
Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994) · Science · doi:10.1126/science.8171322 · Cited by 986
Mechanisms That Regulate the Function of the Selectins and Their Ligands
VESTWEBER, D., & BLANKS, J. E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.181 · Cited by 932
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Balkwill, F. R., & Burke, F. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90085-6 · Cited by 783
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 738
Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., & Weissmann, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.9991 · Cited by 725
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
Fiers, W. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80803-b · Cited by 694
Self-citationRuddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Smith, C. W., Rothlein, R., Hughes, B. J., Mariscalco, M. M., Rudloff, H. E., Schmalstieg, F. C., & Anderson, D. C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113788 · Cited by 599
Vilcek, J., & Lee, T. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89445-9 · Cited by 582
Ledebur, H. C., & Parks, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.933 · Cited by 545
Kishimoto, T. K., Larson, R. S., Corbi, A. L., Dustin, M. L., Staunton, D. E., & Springer, T. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60653-7 · Cited by 524
Self-citationCytokines as communication signals between leukocytes and endothelial cells
Mantovani, A., & Dejana, E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90270-3 · Cited by 517
Soares, M. P., Seldon, M. P., Gregoire, I. P., Vassilevskaia, T., Berberat, P. O., Yu, J., Tsui, T.-Y., & Bach, F. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3553 · Cited by 465
MicroRNA-181b regulates NF-κB–mediated vascular inflammation
Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Vera, M. P., Blackwell, T. S., Baron, R. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61495 · Cited by 444
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Sherry, B., & Cerami, A. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1269 · Cited by 432
Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.
Kratz, A., Campos-Neto, A., Hanson, M. S., & Ruddle, N. H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1461 · Cited by 431
Smith, C. W., Kishimoto, T. K., Abbassi, O., Hughes, B., Rothlein, R., McIntire, L. V., Butcher, E., Anderson, D. C., & Abbass, O. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115037 · Cited by 418
Micro RNA ‐146 represses endothelial activation by inhibiting pro‐inflammatory pathways
Cheng, H. S., Sivachandran, N., Lau, A., Boudreau, E., Zhao, J. L., Baltimore, D., Delgado‐Olguin, P., Cybulsky, M. I., & Fish, J. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202318 · Cited by 417
Membrane Proteins Involved in Phagocyte Adherence to Endothelium
Carlos, T. M., & Harlan, J. M. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00559.x · Cited by 397
Mackay, F., Loetscher, H., Stueber, D., Gehr, G., & Lesslauer, W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1277 · Cited by 395
Dougherty, G. J., Murdoch, S., & Hogg, N. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180107 · Cited by 341
Background Review and Current Concepts of Reperfusion Injury
Hallenbeck, J. M., & Dutka, A. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110107027 · Cited by 327
Nakajima, H., Sano, H., Nishimura, T., Yoshida, S., & Iwamoto, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1145 · Cited by 304
Wong, D., & Dorovini-Zis, K. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90170-p · Cited by 301
Purification and biologic characterization of a specific tumor necrosis factor α inhibitor
Seckinger, P., Isaaz, S., & Dayer, J. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80161-2 · Cited by 291
Larson, R. S., Corbi, A. L., Berman, L., & Springer, T. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.2.703 · Cited by 289
Self-citationEbnet, K., & Vestweber, D. (1999) · Histochemistry and Cell Biology · doi:10.1007/s004180050387 · Cited by 278
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
Zuany-Amorim, C., Hailé, S., Leduc, D., Dumarey, C., Huerre, M., Vargaftig, B. B., & Pretolani, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117966 · Cited by 276
E-selectin supports neutrophil rolling in vitro under conditions of flow.
Abbassi, O., Kishimoto, T. K., McIntire, L. V., Anderson, D. C., & Smith, C. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116889 · Cited by 262
The adhesion molecules of inflammation
Cronstein, B. N., & Weissmann, G. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360204 · Cited by 259
Wertheimer, S. J., Myers, C. L., Wallace, R. W., & Parks, T. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49801-3 · Cited by 257
Jones, C. A., Cayabyab, R. G., Kwong, K. Y. C., Stotts, C., Wong, B., Hamdan, H., Minoo, P., & Delemos, R. A. (1996) · Pediatric Research · doi:10.1203/00006450-199606000-00007 · Cited by 252
Differential regulation of endothelial cell activation by complement and interleukin 1α
Brunn, G. J., Saadi, S., & Platt, J. L. (2006) · Circulation Research · doi:10.1161/01.res.0000216071.87981.16 · Cited by 47
SMITH, D. J., HAMBLIN, A. S., & EDINGTON, N. (2001) · Equine Veterinary Journal · doi:10.1111/j.2042-3306.2001.tb00591.x · Cited by 39
SMITH, D., HAMBLIN, A., & EDINGTON, N. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01463.x · Cited by 30
Metadata
- Authors
- Pober, J. S., Lapierre, L. A., Stolpen, A. H., Brock, T. A., Springer, T. A., Fiers, W., Bevilacqua, M. P., Mendrick, D. L., & Gimbrone, M. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-05
- Volume
- 138
- Issue
- 10
- Pages
- 3319-3324
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1587142652
- Cited by
- 416
- References
- 0
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.